Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422745 · ClinicalTrials.gov registry record · Phase 4
COcoa Supplement and Multivitamin Outcomes Study
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 21,442
- Enrollment target
NCT02422745 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 21,442 participants.
The verdict
NCT02422745, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21,442 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether taking daily, dietary supplements of cocoa extract (containing cocoa flavanols and theobromine from the cocoa bean) and/or a standard multivitamin reduces the risk of developing cardiovascular disease (including heart attack, stroke, coronary revascularization, unstable angina or acute coronary syndrome (ACS) requiring hospitalization, carotid artery surgery, and peripheral artery surgery or angioplasty, and cardiovascular mortality) and cancer.
Interventions
- DIETARY_SUPPLEMENT Multivitamin
- DIETARY_SUPPLEMENT Cocoa extract
- DIETARY_SUPPLEMENT Cocoa extract placebo
- DIETARY_SUPPLEMENT Multivitamin placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,442 participants |
| Start Date | 2015-06 |
| Est. Completion | 2023-06-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422745
The ClinicalTrials.gov registry entry for NCT02422745 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21,442 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Multivitamin is the first listed.
NCT02422745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02422745 about?
NCT02422745 is a clinical study titled "COcoa Supplement and Multivitamin Outcomes Study". The purpose of this study is to determine whether taking daily, dietary supplements of cocoa extract (containing cocoa flavanols and theobromine from the cocoa bean) and/or a standard multivitamin reduces the risk of developing cardiovascular disease (including heart attack, stroke, coronary revascu...
What is the current status of trial NCT02422745?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21,442 participants. The study started on 2015-06. Estimated completion is 2023-06-05.
What interventions are being tested in trial NCT02422745?
The interventions under investigation include: Multivitamin (DIETARY_SUPPLEMENT), Cocoa extract (DIETARY_SUPPLEMENT), Cocoa extract placebo (DIETARY_SUPPLEMENT), Multivitamin placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02422745?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.